Purpose of this Study
We are doing this study to find out if a study device, called the Medtronic INVOS PM7100 Cerebral Oximetry Monitor, is accurate. This device measures how much oxygen is in your brain.
Who Can Participate?
Eligibility
Adults ages 18-50 who:
- Are in good general health
- Do not take daily medications (dietary supplements, birth control, and seasonal allergy medications are allowed)
- Do not have any heart or breathing conditions
- Can pass a urine drug screen (includes testing for Delta-8 and -9 THC metabolites)
- Do not smoke, vape, or use any other nicotine product
Age Range
18-50
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
Yes
What is Involved?
Description
If you choose to join this study, you will make 2 visits to our clinic. The first visit will last about 2 hours and confirm whether or not you are eligible to participate. The second visit will last about 4 hours.
During the second visit, we will see how well the study device works. We will test it by making your body temporarily have low oxygen. You will wear sensors on your fingers and forehead while breathing air with less oxygen.
Also, small tubes will be put into your forearm and neck to get blood samples. We'll check how much oxygen is in these samples. Then, we'll compare these results with what the study device shows. The study device has been approved by the FDA.
We will pay you for your time on the study. The study's compensation is as follows:
- Compensation for first visit: $75 ($100 if you are not eligible to come in for the second visit)
- Compensation for second visit: $1125
Locations
Pickett Road Research
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Accuracy performance verification of the INVOS? PM7100 System by comparing rSO2 values to reference blood oxygen saturation measurements in adult human volunteers.
Principal Investigator
David
MacLeod
Protocol Number
PRO00115806
NCT ID
NCT06581835
Phase
N/A
Enrollment Status
Open to Enrollment